Mogamulizumab-Associated Rash in Patients With Mycosis Fungoides and Sezary Syndrome

被引：0
|
作者：
Foley, Nicole [1 ]
Minor, Chelsea [1 ]
Musiek, Amy [1 ]
Mehta-Shah, Neha [1 ]
机构：
[1] Washington Univ, Sch Med, St Louis, MO USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷
关键词：
mycosis fungoides; Sezary syndrome; cutaneous T-cell lymphoma; mogamulizumab; mogamulizumab-associated rash;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TCL-060
引用
收藏
页码：S464 / S464
页数：1
相关论文
共 50 条
  • [1] Mogamulizumab-Associated Rash in Patients with Mycosis Fungoides or Sezary Syndrome: A Real-World Analysis
    Lohray, R.
    Ebinama, U.
    Nair, R.
    Iyer, S.
    EUROPEAN JOURNAL OF CANCER, 2024, 211 : S49 - S49
  • [2] Clinical Characterization of Mogamulizumab-Associated Rash During Treatment of Mycosis Fungoides or Sezary Syndrome
    Hirotsu, Kelsey E.
    Neal, Tatiana M.
    Khodadoust, Michael S.
    Wang, Jennifer Y.
    Rieger, Kerri E.
    Strelo, Jenna
    Hong, Eric
    Kim, Youn H.
    Kwong, Bernice Y.
    JAMA DERMATOLOGY, 2021, 157 (06) : 700 - 707
  • [3] Change in Lymphocyte Count as a Predictor of Response to Mogamulizumab in Patients with Mycosis Fungoides or Sezary Syndrome
    Foss, Francine
    Ito, Takahiro
    Dwyer, Karen
    Herr, Fiona
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S412 - S412
  • [4] Mogamulizumab in the treatment of advanced mycosis fungoides and Sezary syndrome: safety and efficacy
    Lewis, Daniel J.
    Rook, Alain H.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2020, 20 (06) : 447 - 452
  • [5] Acneiform Case of Mogamulizumab-associated rash
    Booken, N.
    Schneider, S.
    EUROPEAN JOURNAL OF CANCER, 2024, 211 : S66 - S67
  • [6] Histopathologic Characterization of Mogamulizumab-associated Rash
    Wang, Jennifer Y.
    Hirotsu, Kelsey E.
    Neal, Tatiana M.
    Raghavan, Shyam S.
    Kwong, Bernice Y.
    Khodadoust, Michael S.
    Brown, Ryanne A.
    Novoa, Roberto A.
    Kim, Youn H.
    Rieger, Kerri E.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2020, 44 (12) : 1666 - 1676
  • [7] Mogamulizumab combined with extracorporeal photopheresis for the treatment of refractory mycosis fungoides and Sezary syndrome
    Rubio Muniz, C. A.
    Tarin Vicente, E. J.
    Arroyo Andres, J. A.
    Agud De Dios, M. A.
    Vico Alonso, C.
    Sanchez Velazquez, A.
    Postigo Llorente, C.
    Ortiz-Romero, P. L.
    EUROPEAN JOURNAL OF CANCER, 2022, 173 : S51 - S52
  • [8] FDA Approval Summary: Mogamulizumab-kpkc for Mycosis Fungoides and Sezary Syndrome
    Kasamon, Yvette L.
    Chen, Haiyan
    de Claro, R. Angelo
    Nie, Lei
    Ye, Jingjing
    Blumenthal, Gideon M.
    Farrell, Ann T.
    Pazdur, Richard
    CLINICAL CANCER RESEARCH, 2019, 25 (24) : 7275 - 7280
  • [9] Head and neck granulomatous rash associated with mogamulizumab mimicking mycosis fungoides
    Wang, Jingying
    Ram-Wolff, Caroline
    Dobos, Gabor
    Al Hage, Jana
    Grange, Florent
    Rivet, Jacqueline
    Vignon-Pennamen, Marie-Dominique
    Moins-Teisserenc, Helene
    Boisson, Marie
    Moegle, Celine
    Sadoux, Aurelie
    Mourah, Samia
    Battistella, Maxime
    Bagot, Martine
    de Masson, Adele
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 (01) : 129 - 131
  • [10] Granulomatous rash associated with mogamulizumab mimicking mycosis fungoides: a case series
    Wang, Jingying
    de Masson, Adele
    Ram-Wolff, Caroline
    Dobos, Gabor
    Al Hage, Jana
    Rivet, Jacqueline
    Vignon-Pennamen, Marie-Dominique
    Moins-Teisserenc, Helene
    Boisson, Marie
    Sadoux, Aurelie
    Mourah, Samia
    Battistella, Maxime
    Bagot, Martine
    EUROPEAN JOURNAL OF CANCER, 2021, 156 : S49 - S49
12345